Orthofix Medical (OFIX) Cost of Revenue (2010 - 2026)

Orthofix Medical (OFIX) has 17 years of Cost of Revenue data on file, last reported at $57.2 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue fell 20.64% year-over-year to $57.2 million; the trailing twelve-month figure through Mar 2026 stood at $241.4 million (down 8.64% YoY), and the FY2025 full-year result was $256.3 million, up 1.06% from the prior year.
• Cost of Revenue for Q1 2026 stood at $57.2 million, down from $63.6 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $72.0 million in Q1 2025 and bottomed at -$27.6 million in Q4 2023.
• A 5-year average of $52.0 million and a median of $61.6 million in 2024 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue tumbled 183.56% in 2023 and soared 341.92% in 2024, its largest moves.
• Tracing OFIX's Cost of Revenue over 5 years: stood at $33.1 million in 2022, then plunged by 183.56% to -$27.6 million in 2023, then soared by 341.92% to $66.8 million in 2024, then slipped by 4.86% to $63.6 million in 2025, then dropped by 10.08% to $57.2 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $57.2 million, $63.6 million, and $57.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison